Sigma Healthcare Withdraws From Boots Sale Process (opens original article in a new tab)

Sigma Healthcare withdrew from the Boots sale process, citing strategic and capital investment concerns, after considering a potential $10 billion acquisition of the British pharmacy chain.

• Sigma Healthcare withdrew from the Boots sale process.
• The potential deal could have been worth up to $10 billion.
• Sigma stated the acquisition wouldn't meet its strategic and capital investment objectives.